Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients

OBJECTIVE: To explore the efficacy and safety of intermittent, oral famciclovir prophylaxis for bortezomib-induced herpes zoster in multiple myeloma patients. METHOD: We retrospectively analyzed the incidence of bortezomib treatment-related varicella-zoster virus reactivation in 719 newly-diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Gaofeng, Guan, Fangshu, Han, Xiaoyan, Yang, Li, Zhao, Yi, Yang, Yang, Zhang, Enfang, He, Jingsong, He, Donghua, Wu, Wenjun, Huang, He, Cai, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965704/
https://www.ncbi.nlm.nih.gov/pubmed/35372089
http://dx.doi.org/10.3389/fonc.2022.843032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965704/
https://www.ncbi.nlm.nih.gov/pubmed/35372089
http://dx.doi.org/10.3389/fonc.2022.843032

Ejemplares similares